Domenica Lorusso

Domenica Lorusso is a gynecologic oncologist and founding member of MITO (Multicenter Italian Trials in Ovarian Cancer) who has led Italian clinical trial development for rare gynecologic malignancies including carcinosarcoma. She has coordinated Italian registry analyses examining outcomes of uterine and ovarian carcinosarcoma and has contributed to early-phase trials of bevacizumab, PARP inhibitors, and checkpoint inhibitor combinations in carcinosarcoma. She participates in ENGOT and ESGO rare tumor working groups and is an advocate for dedicated carcinosarcoma-specific clinical trial arms.